Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
about
FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-κB to promote survival of human B cellsHomeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics.Solution structure and backbone dynamics of the DNA-binding domain of FOXP1: Insight into its domain swapping and DNA bindingmiR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1MicroRNAs in B-cell lymphomas: how a complex biology gets more complexImmunohistochemical and molecular characteristics with prognostic significance in diffuse large B-cell lymphoma.The significance of FOXP1 in diffuse large B-cell lymphoma.Dural MALT lymphoma with disseminated disease.C-MYC overexpression predicts aggressive transformation and a poor outcome in mucosa-associated lymphoid tissue lymphomasClonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset.Clinical impact of genetic aberrations in gastric MALT lymphoma: a comprehensive analysis using interphase fluorescence in situ hybridisation.Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice.Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1.Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists.Diffuse large B-cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities.Molecular pathways in follicular lymphoma.Gastrointestinal B-cell lymphomas: From understanding B-cell physiology to classification and molecular pathologyPredicting the outcome in non-Hodgkin lymphoma with molecular markers.Mucosa-associated lymphoid tissue lymphoma: molecular pathogenesis and clinicopathological significance.FOXP1: a potential therapeutic target in cancer.Prognostic value of decreased FOXP1 protein expression in various tumors: a systematic review and meta-analysisPrognostic Significance of in situ Phenotypic Marker Expression in Diffuse Large B-cell Lymphomas.Non-IG aberrations of FOXP1 in B-cell malignancies lead to an aberrant expression of N-truncated isoforms of FOXP1.Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas.The role of radiotherapy in the treatment of gastric mucosa-associated lymphoid tissue lymphoma.Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomasPrimary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting.Helicobacter pylori infection, chronic inflammation, and genomic transformations in gastric MALT lymphomaMolecular pathogenesis of lymphomas of mucosa-associated lymphoid tissue--from (auto)antigen driven selection to the activation of NF-κB signaling.The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells.FOXP1 is a regulator of quiescence in healthy human CD4+ T cells and is constitutively repressed in T cells from patients with lymphoproliferative disorders.Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.Expression of FOXP1 and Colorectal Cancer Prognosis.The forkhead transcription factor FOXP1 represses human plasma cell differentiationFOXP1 acts through a negative feedback loop to suppress FOXO-induced apoptosis.Downregulation of FOXP1 is required during germinal center B-cell function.Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium.Expression of FOXP1 in epithelial ovarian cancer (EOC) and its correlation with chemotherapy resistance and prognosis.Gastric mucosa-associated lymphoid tissue lymphomas and Helicobacter pylori infection: a Colombian perspective
P2860
Q24304887-E0DD0A60-DD41-44C2-9AC3-4E0864E05E1BQ27312570-8952F68F-3778-4040-B16E-3D59DA995B7CQ27667284-E0AB801C-E17D-45C4-884D-CE83F32D5A3BQ28239225-043334F5-B64C-4DC1-B872-9F941F16DF45Q28254647-70FF0469-EBD1-40EB-B273-78148C085663Q33700531-48370DD8-E4BF-4E92-BA8E-BA871B77C285Q34047455-473A2AC2-2F65-41C7-8279-74D596D86A24Q34106537-98041BBB-EDB2-44E3-988D-442B1ACC836BQ34371250-79B22A68-3B3A-42C2-A24B-93A7298BA218Q35029961-75EA0B70-022D-4CAE-96D3-B2E72C8DF855Q36023405-F59A82C3-1318-4E3A-A6A6-31B4173B0868Q36068948-91ABD2AE-AB68-4A6C-B60F-54492BEE2579Q36563205-EA701CD6-4B68-4062-B0D1-936C278C424CQ36584820-0B3753B4-C045-4A38-8E05-5C4B9381BDBFQ36622610-07A7187F-D1F3-4CE0-9160-375F5EDD730EQ36622615-C43468F9-6EBD-4480-884F-48163F639C0BQ36637130-BA3664A6-B903-4A7F-8318-DA00412AB219Q36780164-6CD366B2-FE21-4A5A-9203-E898035503D6Q36870112-4EAB73B1-BE31-452E-80C5-C5819EDAE47FQ36871999-1FD354BA-6F26-4441-92E8-C0FE133B9278Q37125561-8A067694-590C-4907-AFF1-8B481BDE9480Q37280910-A5D46AAA-F2FD-4158-9AA1-1ADD3E1BC102Q37458938-DA7B5661-021E-4548-97CC-772601BAEC94Q37553676-99B3AE8C-F791-4150-9BAF-9E2D1101F8EEQ37570360-163F948E-B3AF-44A6-8A0B-6ADCEA453EF1Q37578581-C97F4EB8-E7B0-4AD5-A6EF-BCAB9EFF6E49Q37725413-AB33A722-4767-40B6-B134-CD4EB6C356C0Q38100784-7DDE6EB3-89AA-435D-AF6E-80B69A87F287Q38649807-386F2B5C-8383-4688-97B0-DB208945E36BQ38727975-924BB2A2-CC3F-488B-812A-9772A10948DCQ38730434-82AC86B2-9D76-4FB0-B684-05F4EC3DE05AQ38819164-B2E7B8F6-220F-4773-857D-9C165C5901C9Q38826119-D992467D-EDC8-48B3-9E0E-FA9C730D2997Q38842444-359E65AB-A1FB-4059-8EB5-E813C83676DCQ39129282-A285D0BC-3858-4BFB-8266-D56A8ED22941Q39167447-043B51C6-9498-4CA8-B455-2D2549092573Q39565441-A4EFAF68-645B-41E1-B813-476B185E5134Q40605909-E45DA643-6C21-43C4-A1A4-45BD80140936Q41037797-3F8CAC2D-7A86-42D0-A3B0-6ADA65D9C153Q41198857-613DCEFF-84B5-44CD-8A95-A2F90137336F
P2860
Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Forkhead box protein P1 expres ...... diffuse large B-cell lymphoma.
@ast
Forkhead box protein P1 expres ...... diffuse large B-cell lymphoma.
@en
Forkhead box protein P1 expres ...... diffuse large B-cell lymphoma.
@nl
type
label
Forkhead box protein P1 expres ...... diffuse large B-cell lymphoma.
@ast
Forkhead box protein P1 expres ...... diffuse large B-cell lymphoma.
@en
Forkhead box protein P1 expres ...... diffuse large B-cell lymphoma.
@nl
prefLabel
Forkhead box protein P1 expres ...... diffuse large B-cell lymphoma.
@ast
Forkhead box protein P1 expres ...... diffuse large B-cell lymphoma.
@en
Forkhead box protein P1 expres ...... diffuse large B-cell lymphoma.
@nl
P2093
P50
P356
P1476
Forkhead box protein P1 expres ...... diffuse large B-cell lymphoma.
@en
P2093
Jose Thomas
Louis Libbrecht
Pascale de Paepe
Vera Vanhentenrijk
P304
P356
10.1200/JCO.2006.05.6150
P407
P577
2006-04-24T00:00:00Z